首页> 美国卫生研究院文献>Cancers >Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer

【2h】

Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer

机译：B4GALT1甲基化的诊断和预后价值及其在结直肠癌中作为新型循环无细胞DNA生物标志物的临床意义

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Cancers
作者
Francesco Picardo; Antonella Romanelli; Laura Muinelo-Romay; Tommaso Mazza; Caterina Fusilli; Paola Parrella; Jorge Barbazán; Rafael Lopez-López; Raffaela Barbano; Mariangela De Robertis; Chiara Taffon; Veronica Bordoni; Chiara Agrati; Manuela Costantini; Francesca Ricci; Paolo Graziano; Evaristo Maiello; Lucia Anna Muscarella; Vito Michele Fazio; Maria Luana Poeta;
展开▼
作者单位

展开▼
年(卷),期 2019(11),10
年度 2019
页码 -1
总页数 16
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
colorectal cancer; predictive biomarker; cetuximab; liquid biopsy; cfDNA;

机译：大肠癌预测生物标志物西妥昔单抗液体活检cfDNA;

相似文献

外文文献
中文文献
专利

1. Colorectal cancer diagnostics: Biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis [J] . KinC., KidessE., PoultsidesG.A., Expert Review of Molecular Diagnostics . 2013,第6期

机译：大肠癌诊断：生物标志物，无细胞DNA，循环肿瘤细胞并通过单细胞分析确定异质群体
2. Letter to the Editor: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy” [J] . Chiara Nicolazzo, Cristina Raimondi, Flavia Loreni, International Journal of Molecular Sciences . 2017,第6期

机译：致编辑的信：“循环无细胞DNA和循环肿瘤细胞是一线化疗治疗的晚期非小细胞肺癌患者的预后和预测生物标志物”
3. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy [J] . Simona Coco, Angela Alama, Irene Vanni, International Journal of Molecular Sciences . 2017,第5期

机译：一线化疗治疗晚期非小细胞肺癌患者的循环无细胞DNA和循环肿瘤细胞作为预后和预测生物标志物。
4. Circulating Cell-Free DNA-Based qMSP Demonstrates That Sydecan2 Methylation as a Promising Epigenetic Biomarker for Early Detection of Patients with Precancerous and Cancerous Colorectal Lesions [C] . Sungwhan An, TaeJeong Oh, Dongjun Jeong, Molecular Medicine TRI-CON. . 2014

机译：循环无细胞的DNA基QMSP证明了Sydecan2甲基化作为有望的表观遗传生物标志物，用于早期检测患癌前和癌细胞病患者的患者
5. Search for DNA methylation biomarkers in the circulating DNA of prostate and colorectal cancer. [D] . Park, Mina. 2012

机译：在前列腺癌和结肠直肠癌的循环DNA中寻找DNA甲基化生物标记。
6. Clinical and biological significance of circulating tumor cells circulating tumor DNA and exosomes as biomarkers in colorectal cancer [O] . Shiyu Jia, Rui Zhang, Ziyang Li, 2017

机译：循环肿瘤细胞循环肿瘤DNA和外来体作为结直肠癌生物标志物的临床和生物学意义
7. Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy [O] . J. Hamfjord, T. Guren, O. Dajani, 2018

机译：在一线奥克拉利铂的化疗之前，总循环无细胞DNA（CFDNA）作为转移结直肠癌中的预后生物标志物

Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer

著录项

相似文献

相关主题

期刊订阅